Home › Compare › MOND vs JNJ

MOND vs JNJ: Dividend Comparison 2026

MOND yields 200000.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MOND wins by $4.911780474428384e+29M in total portfolio value
10 years
MOND
MOND
● Live price
200000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.911780474428384e+29M
Annual income
$490,695,411,370,591,700,000,000,000,000,000,000.00
Full MOND calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — MOND vs JNJ

📍 MOND pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMONDJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MOND + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
MOND pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MOND
Annual income on $10K today (after 15% tax)
$17,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$417,091,099,665,002,940,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, MOND beats the other by $417,091,099,665,002,940,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MOND + JNJ for your $10,000?

MOND: 50%JNJ: 50%
100% JNJ50/50100% MOND
Portfolio after 10yr
$2.455890237214192e+29M
Annual income
$245,347,705,685,295,860,000,000,000,000,000,000.00/yr
Blended yield
99.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MOND
Analyst Ratings
6
Buy
Consensus: Buy
Price Target
$13.00
+1299900.0% upside vs current
Range: $13.00 — $13.00
Altman Z
-1.3
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MOND buys
0
JNJ buys
0
No recent congressional trades found for MOND or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMONDJNJ
Forward yield200000.00% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$4.911780474428384e+29M$20.0K ✓
Annual income after 10y$490,695,411,370,591,700,000,000,000,000,000,000.00 ✓$827.78
Total dividends collected$4.911464459982279e+29M$5.6K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$13.00$228.73 ✓

Year-by-year: MOND vs JNJ ($10,000, DRIP)

YearMOND PortfolioMOND Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$20,010,700$20,000,000.00$10,676$355.77+$20.00M → MOND
2$37,424,589,019$37,403,177,570.09$11,407$389.39+$37424.58M → MOND
3$65,416,215,188,220$65,376,170,877,969.18$12,198$426.53+$65416215.18M → MOND
4$106,868,230,495,008,900$106,798,235,144,757,520.00$13,056$467.62+$106868230495.00M → MOND
5$163,172,871,735,896,870,000$163,058,522,729,267,200,000.00$13,987$513.12+$163172871735896.88M → MOND
6$232,854,599,801,468,860,000,000$232,680,004,828,711,460,000,000.00$14,998$563.56+$232854599801468864.00M → MOND
7$310,570,858,137,017,100,000,000,000$310,321,703,715,229,540,000,000,000.00$16,098$619.52+$310570858137017057280.00M → MOND
8$387,148,154,301,613,200,000,000,000,000$386,815,843,483,406,600,000,000,000,000.00$17,295$681.69+$3.871481543016132e+23M → MOND
9$451,061,749,763,281,040,000,000,000,000,000$450,647,501,238,178,360,000,000,000,000,000.00$18,599$750.82+$4.510617497632811e+26M → MOND
10$491,178,047,442,838,440,000,000,000,000,000,000$490,695,411,370,591,700,000,000,000,000,000,000.00$20,022$827.78+$4.911780474428384e+29M → MOND

MOND vs JNJ: Complete Analysis 2026

MOND — Stock

Mondee Holdings, Inc. operates as a travel technology, service, and content company in the leisure and corporate travel markets. It delivers a technology platform of SaaS, mobile, and cloud products and services to a global customer base. The company is connecting a network of 50,000 leisure travel advisors and gig economy workers to 500 airlines and approximately 1 million hotel and vacation rentals, packaged solutions, and ancillary offerings. The company was founded in 2011 and is headquartered in Austin, Texas with 17 offices in the U.S. and Canada, and operations in India, Thailand, and Ireland.

Full MOND Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this MOND vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MOND vs SCHDMOND vs JEPIMOND vs OMOND vs KOMOND vs MAINMOND vs ABBVMOND vs MRKMOND vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.